The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis

Myelodysplastic syndromes (MDS) are a group of heterogeneous clonal stem cell disorders characterized by ineffective hematopoiesis with dysplastic changes in one or more myeloid cell lines and increased risk of progression to acute leukemia. The current diagnosis criteria include the morphology of p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revista română de medicină de laborator 2013, Vol.21 (3), p.343-351
Hauptverfasser:	Tatic, Aurelia, Jardan, Cerasela, Georgescu, Otilia, Stanca, Oana, Vasilica, Madalina, Badelita, Sorina, Crisan, Ana Manuela, Colita, Adriana, Colita, Dan, Vulcan, Genica, Lupu, Anca Roxana, Iosif, Ionel, Coriu, Daniel
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Biopsy Bone marrow International Prognostic Scoring System (IPSS) myelodisplastic syndromes Revised International Prognostic Scoring System (R-IPSS) sindroame mielodisplazice Sistemul de Scor Prognostic Internaţional (IPSS) Sistemul de Scor Prognostic InternaţionalRevizuit (IPSS-R)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!